Developing and Validating Food-based Dietary Guidelines and a Healthy Eating Index
Launched by ETHIOPIAN PUBLIC HEALTH INSTITUTE · Jan 3, 2018
Trial Information
Current as of July 24, 2025
Completed
Keywords
ClinConnect Summary
Triple burden of malnutrition (i.e. protein-energy malnutrition including micronutrient deficiency and overnutrition) is a current global problem. In 2017, 155 out of 677 million children in the world under the age of 5 years were stunted (height for age \< -2 SD of the WHO Child Growth Standards median), 52 million wasted (weight for height \< -2 SD of the WHO child growth standards median) and 41 million overweight (weight for height \> 2 SD of the WHO child growth standards median) with 93 million children at risk of overweight. Out of 5 billion adults worldwide, nearly 2 billion are ove...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • General population above 2 years of FBDGs development
- • Women of reproductive age (15-49 years) for FBDGs validation
- • Women of reproductive age (15-49 years) for HEI development and validation
- Exclusion Criteria:
- • population groups other than women of reproductive age for FBDGs validation, and HEI development and validation.
About Ethiopian Public Health Institute
The Ethiopian Public Health Institute (EPHI) is a leading governmental organization dedicated to enhancing public health in Ethiopia through research, surveillance, and capacity building. Established to address the nation's health challenges, EPHI plays a pivotal role in the design and implementation of clinical trials aimed at advancing medical knowledge and improving healthcare outcomes. With a commitment to evidence-based practices, EPHI collaborates with national and international partners to ensure that research initiatives align with global health standards and local needs. Through its robust infrastructure and expertise, EPHI is instrumental in fostering innovation in public health interventions and promoting sustainable health solutions across Ethiopia.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Addis Ababa, , Ethiopia
Patients applied
Trial Officials
Inge D Brouwer, PhD
Study Director
Wageningen University
Edith Feskens, Prof., PhD
Study Chair
Wageningen University
Jeanne de Vries, PhD
Study Chair
Wageningen University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials